| COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings M Nehme, O Braillard, G Alcoba, S Aebischer Perone, D Courvoisier, ... Annals of internal medicine 174 (5), 723-725, 2021 | 247 | 2021 |
| Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland J Perez-Saez, SA Lauer, L Kaiser, S Regard, E Delaporte, I Guessous, ... The Lancet Infectious Diseases 21 (4), e69-e70, 2021 | 244 | 2021 |
| Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting M Nehme, O Braillard, F Chappuis, DS Courvoisier, I Guessous, ... Annals of internal medicine 174 (9), 1252-1260, 2021 | 159 | 2021 |
| Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant? P Voruz, A Cionca, I Jacot de Alcântara, A Nuber-Champier, G Allali, ... Brain communications 4 (2), fcac057, 2022 | 51 | 2022 |
| Characteristics of long-COVID among older adults: A cross-sectional study V Daitch, D Yelin, M Awwad, G Guaraldi, J Milić, C Mussini, M Falcone, ... International Journal of Infectious Diseases 125, 287-293, 2022 | 45 | 2022 |
| Patterns of long COVID symptoms: A multi-center cross sectional study D Yelin, I Margalit, M Nehme, J Bordas-Martínez, F Pistelli, D Yahav, ... Journal of Clinical Medicine 11 (4), 898, 2022 | 45 | 2022 |
| Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA. 2 wave in Geneva, Switzerland: a population-based study ME Zaballa, J Perez-Saez, C de Mestral, N Pullen, J Lamour, P Turelli, ... The Lancet Regional Health–Europe 24, 2023 | 33 | 2023 |
| One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals M Nehme, O Braillard, F Chappuis, DS Courvoisier, L Kaiser, PM Soccal, ... Journal of internal medicine 292 (1), 103-115, 2022 | 32 | 2022 |
| Symptoms after COVID-19 vaccination in patients with post-acute sequelae of SARS-CoV-2 M Nehme, O Braillard, J Salamun, F Jacquerioz, DS Courvoisier, ... Journal of general internal medicine 37 (6), 1585-1588, 2022 | 29 | 2022 |
| Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP) M Nehme, S Stringhini, I Guessous Swiss medical weekly 150 (4748), w20398-w20398, 2020 | 26 | 2020 |
| The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization M Nehme, O Braillard, F Chappuis, I Guessous Scientific reports 12 (1), 14505, 2022 | 24 | 2022 |
| Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV‐2 infection P Voruz, A Cionca, I Jacot de Alcântara, A Nuber‐Champier, G Allali, ... Human Brain Mapping 44 (4), 1629-1646, 2023 | 22 | 2023 |
| Prevalence of post-coronavirus disease condition 12 weeks after Omicron infection compared with negative controls and association with vaccination status M Nehme, P Vetter, F Chappuis, L Kaiser, I Guessous Clinical Infectious Diseases 76 (9), 1567-1575, 2023 | 21 | 2023 |
| COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study A Wisniak, H Baysson, N Pullen, M Nehme, F Pennacchio, ME Zaballa, ... medRxiv, 2021.07. 05.21260024, 2021 | 17 | 2021 |
| A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents R Dumont, V Richard, E Lorthe, A Loizeau, F Pennacchio, ME Zaballa, ... Nature communications 13 (1), 7086, 2022 | 14 | 2022 |
| Impact of peritraumatic dissociation in hospitalized patients with COVID-19 pneumonia: A longitudinal study L Benzakour, O Braillard, V Mazzola, D Gex, M Nehme, SA Perone, ... Journal of Psychiatric Research 140, 53-59, 2021 | 12 | 2021 |
| Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence AG L’Huillier, S Pagano, S Baggio, B Meyer, DO Andrey, M Nehme, ... European Journal of Clinical Investigation 52 (10), e13818, 2022 | 11 | 2022 |
| Novel outpatient management of mild to moderate COVID-19 spares hospital capacity and safeguards patient outcome: The Geneva PneumoCoV-Ambu study C Chevallier Lugon, M Smit, J Salamun, M Abderrahmane, O Braillard, ... PLoS One 16 (3), e0247774, 2021 | 10 | 2021 |
| The prevalence, severity, and impact of post-COVID persistent fatigue, post-exertional malaise, and chronic fatigue syndrome M Nehme, F Chappuis, L Kaiser, F Assal, I Guessous Journal of General Internal Medicine 38 (3), 835-839, 2023 | 8 | 2023 |
| Markers of limbic system damage following SARS-CoV-2 infection M Thomasson, P Voruz, A Cionca, I Jacot de Alcântara, ... Brain Communications 5 (4), fcad177, 2023 | 8 | 2023 |
